No immediate trading action needed. The filing is a routine governance update with no material effect on operations or financials. Monitor the outcome of the annual meeting for any unexpected changes.
Price Chart
Executive Summary
Sensei Biotherapeutics filed an 8-K disclosing that director nominee Karen Vousden requested a delay in her board appointment to later in 2026 due to personal reasons. The company also intends to appoint Bob Holmen as chair of the Nominating and Corporate Governance Committee and set the board size at five directors, contingent on stockholder approval at the upcoming annual meeting. This is a routine governance update with no financial or operational impact.
Key Facts
- Director nominee Karen Vousden requested to delay her board appointment until Q3 or Q4 2026 for personal reasons.
- Pending stockholder approval, Bob Holmen will be appointed chair of the Nominating and Corporate Governance Committee effective June 12, 2026.
- The board size has been set at five directors effective June 12, 2026.
- Annual meeting of stockholders is scheduled for June 10, 2026.
Financial Impact
No financial impact.
Risk Factors
- Stockholder may not approve the required matters, potentially altering board composition.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-236820 |
| Document: 0001193125-26-236820-index-headers.html | 0001193125-26-236820 |
| Document: 0001193125-26-236820-index.html | 0001193125-26-236820 |
| Document: 0001193125-26-236820.txt | 0001193125-26-236820 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 19w ago | 3 | $13.86 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 8-K | $13.04 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | EFFECT | $13.04 | awaiting T+5 | — | — |
Jun 10, 2026 19w ago | S-3/A | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 10, 2026 19w ago | 8-K | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 2, 2026 21w ago | 10-K/A | $16.10 $12.63 | ▼ −21.53% | ▼ −18.56% | — |
Jun 2, 2026 21w ago | S-3/A | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
Jun 1, 2026 21w ago | Insider Cluster | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
May 22, 2026 22w ago | DEFA14A | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
May 22, 2026 22w ago | 8-K | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers